NICE DG11 faecal calprotectin diagnostic tests for inflammatory diseases of the bowel proposed that faecal calprotectin should be used as part of the assessment of IBD and IBS (NICE, 2013). This consensus document has been developed by experts in the field to assist local health economies to introduce the NICE guidance locally with a view to improve the patient journey and reduce unnecessary referrals to endoscopy services. Increased uptake of the test should produce increased knowledge and evidence, which can be used to enhance NICE DG11.
Professor Sue Hill, Chief Scientific Officer for England